These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 31549618)

  • 1. Detection of
    Mhamilawa LE; Aydin-Schmidt B; Mmbando BP; Ngasala B; Morris U
    Am J Trop Med Hyg; 2019 Nov; 101(5):1144-1147. PubMed ID: 31549618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and Risk Factors Associated with Polymerase Chain Reaction-Determined
    Mwaiswelo R; Ngasala B; Jovel I; Xu W; Larsson E; Malmberg M; Gil JP; Premji Z; Mmbando BP; Mårtensson A
    Am J Trop Med Hyg; 2019 May; 100(5):1179-1186. PubMed ID: 30860013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
    Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
    Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained High Cure Rate of Artemether-Lumefantrine against Uncomplicated
    Mwaiswelo R; Ngasala B; Gil JP; Malmberg M; Jovel I; Xu W; Premji Z; Mmbando BP; Björkman A; Mårtensson A
    Am J Trop Med Hyg; 2017 Aug; 97(2):526-532. PubMed ID: 28829723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda.
    Hopkins H; González IJ; Polley SD; Angutoko P; Ategeka J; Asiimwe C; Agaba B; Kyabayinze DJ; Sutherland CJ; Perkins MD; Bell D
    J Infect Dis; 2013 Aug; 208(4):645-52. PubMed ID: 23633405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of loop-mediated isothermal amplification for malaria diagnosis during a follow-up study in São Tomé.
    Lee PW; Ji DD; Liu CT; Rampao HS; do Rosario VE; Lin IF; Shaio MF
    Malar J; 2012 Dec; 11():408. PubMed ID: 23217163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania.
    Kilonzi M; Minzi O; Mutagonda R; Baraka V; Sasi P; Aklillu E; Kamuhabwa A
    Malar J; 2020 Feb; 19(1):66. PubMed ID: 32046718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of non-instrumented nucleic acid amplification by loop-mediated isothermal amplification (NINA-LAMP) for the diagnosis of malaria in Northwest Ethiopia.
    Sema M; Alemu A; Bayih AG; Getie S; Getnet G; Guelig D; Burton R; LaBarre P; Pillai DR
    Malar J; 2015 Jan; 14():44. PubMed ID: 25626339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of the loop-mediated isothermal amplification (LAMP) based illumigene
    De Koninck AS; Cnops L; Hofmans M; Jacobs J; Van den Bossche D; Philippé J
    Malar J; 2017 Oct; 16(1):418. PubMed ID: 29041927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy.
    Silva M; Ferreira PE; Otienoburu SD; Calçada C; Ngasala B; Björkman A; Mårtensson A; Gil JP; Veiga MI
    J Antimicrob Chemother; 2019 Jul; 74(7):1890-1893. PubMed ID: 30869127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SYBR green I based visual loop-mediated isothermal amplification (LAMP) assay for genus and species-specific diagnosis of malaria in
    Singh R; Singh DP; Savargaonkar D; Singh OP; Bhatt RM; Valecha N
    J Vector Borne Dis; 2017; 54(1):54-60. PubMed ID: 28352046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Field-Tailored Reverse Transcription Loop-Mediated Isothermal Assay for High Sensitivity Detection of Plasmodium falciparum Infections.
    Kemleu S; Guelig D; Eboumbou Moukoko C; Essangui E; Diesburg S; Mouliom A; Melingui B; Manga J; Donkeu C; Epote A; Texier G; LaBarre P; Burton R; Ayong L
    PLoS One; 2016; 11(11):e0165506. PubMed ID: 27824866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.